Skip to main content
TipRanks
Go Ultimate75% OFF

Duality Biotherapeutics, Inc. (9606) Financial Statements

5 Followers

Duality Biotherapeutics, Inc. Financial Overview

Duality Biotherapeutics, Inc.'s market cap is currently ¥8.47B. The company's EPS TTM is ¥-16.08; its P/E ratio is -4.87; Duality Biotherapeutics, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue¥ 1.80B¥ 1.94B¥ 1.79B¥ 1.60M
Gross Profit¥ 561.85M¥ 784.67M¥ 1.36B¥ 1.60M
Operating Income¥ -416.27M¥ -188.99M¥ 781.36M¥ -368.58M
EBITDA¥ -2.51B¥ -1.01B¥ -197.07M¥ -385.22M
Net Income¥ -2.53B¥ -1.05B¥ -357.51M¥ -387.09M
Balance Sheet
Cash & Short-Term Investments¥ 3.43B¥ 1.39B¥ 1.13B¥ 375.97M
Total Assets¥ 3.89B¥ 2.09B¥ 1.50B¥ 463.74M
Total Debt¥ 149.84M¥ 5.29M¥ 5.32M¥ 4.67M
Net Debt¥ -1.18B¥ -1.20B¥ -1.13B¥ -371.31M
Total Liabilities¥ 1.47B¥ 4.11B¥ 2.62B¥ 1.23B
Stockholders' Equity¥ 2.43B¥ -2.02B¥ -1.12B¥ -769.12M
Cash Flow
Free Cash Flow¥ 180.86M¥ 254.60M¥ 780.43M¥ -321.67M
Operating Cash Flow¥ 194.58M¥ 285.78M¥ 816.34M¥ -299.47M
Investing Cash Flow¥ -1.91B¥ -211.15M¥ -78.55M¥ -22.20M
Financing Cash Flow¥ 1.81B¥ -7.62M¥ 10.82M¥ 451.46M

Currency in CNY

Duality Biotherapeutics, Inc. Earnings and Revenue History

-5B-2.5B02.5B-30000 %-20000 %-10000 %0 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin

Duality Biotherapeutics, Inc. Liabilities to Assets

01.5B3B4.5B0 %100 %200 %300 %LiabilitiesLiabilities to Assets2022202320242025AssetsLiabilitiesLiabilities to Assets

Duality Biotherapeutics, Inc. Cash Flow

-3B-2B-1B01B2B2022202320242025OperatingInvestingFinancing

Duality Biotherapeutics, Inc. Forecast EPS vs Actual EPS

-80-60-40-200Q2 25Q4 25Q2 26EPS EstimateBeatMiss